Analysis of cell cycle gene expression responding to acetoxyscirpendiol isolated from Paecilomyces tenuipes

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 1, 2003, Pages 32-36

  Chung, Eui Jung ^a   Choi, Kyungyi ^a   Ha, Won Kim ^a   Lee, Dong Hee ^a  

^a University of Seoul   (South Korea)

Author keywords

Acetoxyscirpendiol; Cell cycle gene; Cyclin C; Gene expression; Mad 1; Paecilomyces tenuipes

Indexed keywords

ACETOXYSCIRPENDIOL; ANTINEOPLASTIC AGENT; CYCLIN C; CYCLINE; HERBACEOUS AGENT; PROTEIN MAD1; UNCLASSIFIED DRUG; CCNC PROTEIN, HUMAN; CELL CYCLE PROTEIN; MAD1L1 PROTEIN, HUMAN; MESSENGER RNA; MYCOTOXIN; NUCLEAR PROTEIN; PHOSPHOPROTEIN; REPRESSOR PROTEIN;

ARTICLE; CELL CYCLE; CELL LINE; CONTROLLED STUDY; DRUG ISOLATION; FUNGUS; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; NONHUMAN; PAECILOMYCES; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; CYCLINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MYCOTOXINS; NUCLEAR PROTEINS; PAECILOMYCES; PHOSPHOPROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0038721146     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.26.32     Document Type: Article

References (19)

1. Zhu J.-S., Halpern G. M., Jones K., Part I. J. Alternative Complementary Medicine, 4, 289-303 (1998a).
2. Zhu J.-S., Haipern G. M., Jones K., Part II. J. Alternative Complementary Medicine, 4, 429-457 (1998b).
3. Nam K. S., Jo Y. S , Kim Y H., Hyun J W., Kim H. W., Life Sci , 69, 229-237 (2001).
4. Wang Z.-X., Wang H.-Y., Wu M.-C., Br. J. Cancer, 85, 1162-1167 (2001).
5. Grana X., Garriga J, Mayol X., Oncogene, 17, 3365-3383 (1998).
6. Huang L., Lang D., Geradts J., Obara T., Klein-Szanto A. J., Lynch H T., Ruggeri B. A., Mol. Carcinog., 15, 85-95 (1996).
7. Lania L., Majello B., Napolitano G., J. Cell. Phys , 179, 134-141 (1999).
8. Vink-van Wijngaarden T., Pols H. A. P., Buurman C. J., van den Bernd G. J. C. M., Dorssers L. C. J., Birkenhäger J. C , van Leeuwen J P. T. M., Cancer Res , 54, 5711-5717 (2000)
9. Yang G. H., Jarvis B B., Chung Y. J., Pestka J. J., Toxicol. App Pharmacol. 164, 149-160 (2000).
10. Shifrin V. I., Anderson P., J Biol Chem., 274, 13985-13992 (1999).
11. Oh G. S., Hong K. H., Oh H., Pae H. O., Kim I. K., Kim N. Y , Kwon T. O., Shin M. K., Chung H. T., Biol. Pharm Bull , 24, 785-789 (2001).
12. Rots N , Iavarone A., Bromleigh V , Freedman L. P., Blood, 93, 2721-2729 (1999).
13. Rickert P., Seghezzi W., Shanahan F., Cho H., Lees E., Oncogene. 12, 2631-2640 (1998)
14. Polly P., Danielsson C., Schrader M., Carlberg C., J Cell Biochem., 77, 75-81 (2000).
15. Liu Z.-J., Ueda T., Miyazaki T., Tanaka N , Mine S., Tartaka Y., Tamguchi T., Yamamura H., Mol. Cell Biol., 18, 3445-3454 (1998).
16. Li H , Lahti J. M., Valentine M., Saito M., Reed S. I., Look A T., Kidd V. J., Genomics, 32, 253-259 (1996).
17. Farr K A., Hoyt M. A., Mol. Cell Biol , 18, 2738-2747 (1998).
18. Hwang L. H., Lau L. F., Smith D. L , Mistrot C A., Hardwick K. G., Hwang E. S., Amon A., Murray A. W., Science, 279, 1041-1044 (1998).
19. Chung E., Chen R. H., Mol. Biol. Cell, 13, 1501-1511 (2002).